辅导式移动应用平台治疗基层医疗患者抑郁与焦虑的随机临床试验
该随机临床试验在阿肯色医科大学内科门诊招募146例抑郁或焦虑筛查阳性的成人基层医疗患者,评估IntelliCare移动干预平台在8周干预期间对抑郁和焦虑的疗效。结果显示干预组抑郁和焦虑的康复比例均高于等待列表对照组,且效果在2个月随访期间维持,应用使用率较高。
要点
- 辅导式移动应用平台可提高基层医疗患者抑郁和焦虑的康复比例。
- 干预效果在2个月随访期间维持,应用使用率较高。
- 数字心理健康干预可设计为可组合的简单应用平台。
核心结论
- 在本试验中,移动干预应用对基层医疗患者的抑郁和焦虑有效。
研究设计与样本
- 两臂随机临床试验,在阿肯色医科大学内科门诊招募146例成人基层医疗患者,抑郁筛查PHQ≥10或焦虑筛查GAD-7≥8。
- 干预组接受辅导支持的移动应用平台8周,等待列表对照组接受常规治疗8周后接受移动平台。
主要发现
- 干预组相比对照组抑郁康复比例更高(38/64[59%] vs 18/58[31%];OR 3.25;95%CI 1.54-6.86)。
- 干预组相比对照组焦虑康复比例更高(37/65[57%] vs 25/66[38%];OR 2.17;95%CI 1.08-4.36)。
- 随访期间抑郁评分斜率0.01(95%CI -0.09至0.10;P=.92),焦虑评分斜率0.02(95%CI -0.08至0.12;P=.67),效果维持。
- 抑郁和焦虑患者的中位应用使用次数分别为93次和98次。
关键数值与推荐
- 抑郁康复定义为PHQ-9<5或较基线改善50%,焦虑康复定义为GAD-7<5或较基线改善50%。
- 抑郁筛查采用PHQ-8评分≥10,焦虑筛查采用GAD-7评分≥8。
临床怎么用
- 基层医疗可考虑使用辅导支持的移动应用平台治疗抑郁和焦虑。
- 数字心理健康干预可设计为包含简单、简短应用的平台,由用户组合以满足需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Depression and anxiety are common and disabling. Primary care is the de facto site for treating these mental health problems but is typically underresourced to meet the burden of these demands. OBJECTIVE: To evaluate the efficacy of a mobile intervention platform, IntelliCare, for addressing depression and anxiety among primary care patients. DESIGN, SETTING, AND PARTICIPANTS: Two-arm randomized clinical trial at internal medicine clinics at the University of Arkansas for Medical Sciences. Adult primary care patients (N = 146) who screened positive for depression on the Patient Health Questionnaire-8 (PHQ; score ≥ 10) or anxiety on the Generalized Anxiety Disorder-7 (GAD-7; score ≥ 8) were recruited between July 17, 2018, and December 14, 2018. INTERVENTIONS: The coach-supported platform composed of a suite of apps, was delivered over 8 weeks. Wait list control participants received treatment as usual for 8 weeks, then the mobile platform. MAIN OUTCOMES AND MEASURES: Primary outcomes were changes in depression (PHQ-9) and anxiety (GAD-7) during the intervention period. Secondary outcomes were differences in the proportion of patients who achieved recovery (PHQ-9/GAD-7 <5 or 50% improvement from baseline), sustainment of intervention effects during 2-month follow-up, and app use during the intervention period. RESULTS: One hundred forty-six patients were included (119 of 146 were women [81.5%]; mean [SD] age, 42.3 [13.8] years). Of the 146 patients, 122 (83.6%) were diagnosed as having depression and 131 (89.7%) were diagnosed as having anxiety. A greater proportion of intervention vs wait list control participants achieved recovery from depression (n = 38 of 64 [59%] vs n = 18 of 58 [31%]; odds ratio, 3.25; 95% CI, 1.54-6.86) and anxiety (n = 37 of 65 [57%] vs n = 25 of 66 [38%]; odds ratio, 2.17; 95% CI, 1.08-4.36). Sustained effects were observed for depression (slope, 0.01; 95% CI, -0.09 to 0.10; P = .92) and anxiety scores (slope, 0.02; 95% CI, -0.08 to 0.12; P = .67) during follow-up. App use was high, with a median of 93 and 98 sessions among participants with depression and anxiety, respectively. CONCLUSIONS AND RELEVANCE: In this trial, a mobile intervention app was effective for depression and anxiety among primary care patients. Findings also support designing digital mental health interventions as platforms containing simple, brief apps that can be bundled by users to meet their needs. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03500536.
引用
- Graham AK, Greene CJ, Kwasny MJ, et al. Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients: A Randomized Clinical Trial. JAMA Psychiatry. 2020. PMID: 32432695. doi:10.1001/jamapsychiatry.2020.1011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。